Drug intelligence / Profile preview

shenqi changtai mixture

Development stage
Unknown
Lead developer
Chongqing Sainuo Biological Pharmaceutical
Modality
Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Shenqi Changtai Mixture (参歧肠泰合剂) is a traditional Chinese medicine (TCM) oral liquid developed and manufactured by Chongqing Sainuo Biological Pharmaceutical. It is primarily indicated for the treatment of gastrointestinal disorders associated with Spleen deficiency, including chronic diarrhea, functional gastrointestinal dysfunction, and intestinal flora imbalance. The formulation typically utilizes herbal extracts such as Codonopsis (Dangshen) and Astragalus (Huangqi) to tonify Qi and strengthen the spleen. According to the developer's pipeline, it is also characterized as a probiotic-related combination therapy, designed to regulate the intestinal microenvironment, restore microbial balance, and improve gastrointestinal mucosal health. It is currently approved and marketed in China.

Brand names
Shenqi Changtai
Other names
参歧肠泰合剂Shenqi Changtai HejiShenqi Changtai Mixture

Beyond the preview

Go deeper on shenqi changtai mixture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shenqi changtai mixture.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call